AU2004287908A1 - Diagnostic methods for congestive heart failure - Google Patents

Diagnostic methods for congestive heart failure Download PDF

Info

Publication number
AU2004287908A1
AU2004287908A1 AU2004287908A AU2004287908A AU2004287908A1 AU 2004287908 A1 AU2004287908 A1 AU 2004287908A1 AU 2004287908 A AU2004287908 A AU 2004287908A AU 2004287908 A AU2004287908 A AU 2004287908A AU 2004287908 A1 AU2004287908 A1 AU 2004287908A1
Authority
AU
Australia
Prior art keywords
glycophorin
antibody
chf
accordance
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004287908A
Other languages
English (en)
Inventor
George Jackowski
Michele Rasamoelisolo
Brad Thatcher
Tracy Van Lieshout
Jason Yantha
Rulin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syn X Pharma Inc
Original Assignee
Syn X Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syn X Pharma Inc filed Critical Syn X Pharma Inc
Publication of AU2004287908A1 publication Critical patent/AU2004287908A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2004287908A 2003-11-11 2004-11-10 Diagnostic methods for congestive heart failure Abandoned AU2004287908A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/706,599 US20050100964A1 (en) 2003-11-11 2003-11-11 Diagnostic methods for congestive heart failure
US10/706,599 2003-11-11
PCT/CA2004/001945 WO2005045436A1 (en) 2003-11-11 2004-11-10 Diagnostic methods for congestive heart failure

Publications (1)

Publication Number Publication Date
AU2004287908A1 true AU2004287908A1 (en) 2005-05-19

Family

ID=34552579

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004287908A Abandoned AU2004287908A1 (en) 2003-11-11 2004-11-10 Diagnostic methods for congestive heart failure

Country Status (6)

Country Link
US (3) US20050100964A1 (de)
EP (1) EP1692513B1 (de)
JP (1) JP4646918B2 (de)
AU (1) AU2004287908A1 (de)
CA (1) CA2544838A1 (de)
WO (1) WO2005045436A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6017422B2 (ja) 2010-08-10 2016-11-02 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） 赤血球結合療法
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
AU2015233084B2 (en) 2014-02-21 2020-12-17 Anokion Sa Glycotargeting therapeutics
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
EP3826676A4 (de) * 2018-10-31 2022-05-04 I-Mab Biopharma US Limited Neuartige cd47-antikörper und verfahren zur verwendung davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
US6190691B1 (en) * 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
ATE489633T1 (de) * 1997-06-10 2010-12-15 Lpath Inc Verfahren zum frühzeitigen nachweis herzerkrankungen
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure

Also Published As

Publication number Publication date
US20050100964A1 (en) 2005-05-12
JP2007510915A (ja) 2007-04-26
CA2544838A1 (en) 2005-05-19
EP1692513A4 (de) 2008-02-20
US20110183436A1 (en) 2011-07-28
WO2005045436A1 (en) 2005-05-19
EP1692513B1 (de) 2012-06-06
US8263351B2 (en) 2012-09-11
EP1692513A1 (de) 2006-08-23
JP4646918B2 (ja) 2011-03-09
US20090068676A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
US8263351B2 (en) Diagnostic methods for congestive heart failure
EP1697746B1 (de) Risikomarker für eine herzkreislaufkrankheit
JP2007515632A5 (de)
US10145853B2 (en) Biomarkers for non-alcoholic fatty liver disease, and methods for detecting non-alcoholic fatty liver disease by using such biomarkers
US7998690B2 (en) Methods for the detection and monitoring of congestive heart failure
JP2018524585A (ja) Ｐｌａ２ｒ１エピトーププロファイルおよびｐｌａ２ｒ１エピトープスプレッディングの分析に基づく膜性腎症の予後およびモニタリング
CA2712309A1 (en) Composition and method for diagnosis or detection of renal cancer
US8278119B2 (en) Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes
Kløverpris et al. Formation of high-molecular-weight angiotensinogen during pregnancy is a result of competing redox reactions with the proform of eosinophil major basic protein
WO2007055340A1 (ja) Ｐｔｘ３高感度測定法
EP1371986A1 (de) Diagnose von Alzheimer basiert auf dem hAbeta42:hAbeta40 Verhältnis
US20180156822A1 (en) Biomarker for cardiac disorders
AU2021216560B2 (en) In vitro method for diagnosing central nervous system injury
KR101977410B1 (ko) 당뇨병에 대한 신규 바이오마커 및 그의 용도
US8841084B2 (en) Methods for the detection and monitoring of acute myocardial infarction
JPH04252955A (ja) 蛋白質の測定方法、試薬及びキット
JP4608570B2 (ja) 新規なモノクローナル抗体及びニックβ２グリコプロテインＩの免疫学的分析方法
US20090081714A1 (en) Assays
AU2011235920B2 (en) Risk markers for cardiovascular disease